For many individuals, a cancer diagnosis brings a whirlwind of medical decisions, emotional adjustments, and physical transformations....
Pevita Pearce
As the Democratic Republic of the Congo (DRC) grapples with a concerning resurgence of the Bundibugyo virus,...
In the rapidly evolving field of human genetics, researchers have long grappled with a fundamental dichotomy: the...
This report is a synthesis of shared experiences from the breast cancer patient and survivor community. The...
Fifty-five years after the Controlled Substances Act of 1970 relegated psilocybin to Schedule I status—placing it alongside...
As the global medical landscape witnesses a seismic shift in how obesity and metabolic health are managed,...
By Editorial Staff May 26, 2026 In the book of Deuteronomy, the ancient directive is clear: "Choose...
For patients navigating the emotional and physical complexities of breast reconstruction, the journey is often fraught with...
For decades, the medical community viewed metabolic dysfunction-associated steatohepatitis (MASH)—formerly known as NASH—as a clinical "graveyard." Despite...
In the high-stakes world of biopharmaceutical manufacturing, the transition from clinical-stage promise to commercial-scale reality is often...
